top of page

PADCEV - New Approved Treatment

YOU ARE CORDIALLY INVITED TO A VIRTUAL PROGRAMPRESENTED BY... A program on an FDA approved treatment option in locally advanced or mUC for patients who have previously received a PD-1 or PD-L1 inhibitor and platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced, or metastatic setting.

PRESENTER Bethany Mooney, MSN, CRNP Medical Oncology Nurse Practitioner Penn Medicine Philadelphia, PA


Kindly Reply by June 15, 2020 In the RSVP, please include your Name, Contact Information, Organization, and Specialty.

DATE AND TIME June 22, 2020 6:00 PM ET


39 views0 comments

Recent Posts

See All

Cancer Equity Colloquium 2024

Now more than ever, the presence of social inequities in healthcare is evident. This two-day, hybrid event, the Cancer Equity Colloquium, will address the diverse issues that underlie cancer inequitie


bottom of page